| Name | Thedacare At Home |
|---|---|
| Organization Name | Thedacare Incorporated |
| Location | 2100 Omro Rd, Ste C, Oshkosh, Wisconsin 54904 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (920) 969-0919 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The Hemophilia Federation of America (HFA) expresses its concern regarding the ongoing labor issues involving the Teamsters Local 929 and the American Red Cross of Pennsylvania /New Jersey.
The Association for Professionals in Infection Control and Epidemiology (APIC) has created a new award to recognize healthcare CEOs and administrators that support infection prevention and control efforts throughout their facilities. The new APIC Healthcare Administrator Award will honor a member of a healthcare facility's executive team (CEO, COO, CFO, CMO, CNO) who has demonstrated significant and sustained support of the organization's infection prevention team.
AHF's Magic Johnson ‘Testing America' Tour, a six month, 48 state national cross country HIV testing tour, arrives in Columbia, South Carolina to host free HIV testing events, along with local partner South Carolina HIV/AIDS Council, today and tomorrow, March 3rd and 4th from 10:00 am to 5:00 pm. All are welcome to attend.
Benitec Limited (ASX: BLT), (PINK:BNIKF), a world leader in expressed gene silencing for human therapeutics, is pleased to announce that the United States Patent and Trademark Office (USPTO) has today indicated that it is issuing the Re-examination Certificate, the formal final step in the USPTO's confirmation of patentability of claims in the key ‘099 Graham Patent [US Patent No. 6,573,099] "Genetic Constructs for Delaying or Repressing the Expression of a Target Gene", the wide-ranging platform technology patent covering the use of expressed RNA interference (RNAi) in human therapeutic applications.
ChemGenex Pharmaceuticals announces that the U.S. Food and Drug Administration's Office of Oncology Drug Products has issued a complete response letter regarding the new drug application for OMAPRO for the treatment of adults with chronic myeloid leukemia who have failed prior therapy with imatinib and have the Bcr-Abl T315I mutation.
› Verified 5 days ago
| NPI Number | 1194812784 |
| Organization Name | THEDACARE, INCORPORATED |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2100 Omro Rd, Unit E, Oshkosh, WI 54904 |
| Phone Number | 920-969-0919 |
News Archive
The Hemophilia Federation of America (HFA) expresses its concern regarding the ongoing labor issues involving the Teamsters Local 929 and the American Red Cross of Pennsylvania /New Jersey.
The Association for Professionals in Infection Control and Epidemiology (APIC) has created a new award to recognize healthcare CEOs and administrators that support infection prevention and control efforts throughout their facilities. The new APIC Healthcare Administrator Award will honor a member of a healthcare facility's executive team (CEO, COO, CFO, CMO, CNO) who has demonstrated significant and sustained support of the organization's infection prevention team.
AHF's Magic Johnson ‘Testing America' Tour, a six month, 48 state national cross country HIV testing tour, arrives in Columbia, South Carolina to host free HIV testing events, along with local partner South Carolina HIV/AIDS Council, today and tomorrow, March 3rd and 4th from 10:00 am to 5:00 pm. All are welcome to attend.
Benitec Limited (ASX: BLT), (PINK:BNIKF), a world leader in expressed gene silencing for human therapeutics, is pleased to announce that the United States Patent and Trademark Office (USPTO) has today indicated that it is issuing the Re-examination Certificate, the formal final step in the USPTO's confirmation of patentability of claims in the key ‘099 Graham Patent [US Patent No. 6,573,099] "Genetic Constructs for Delaying or Repressing the Expression of a Target Gene", the wide-ranging platform technology patent covering the use of expressed RNA interference (RNAi) in human therapeutic applications.
ChemGenex Pharmaceuticals announces that the U.S. Food and Drug Administration's Office of Oncology Drug Products has issued a complete response letter regarding the new drug application for OMAPRO for the treatment of adults with chronic myeloid leukemia who have failed prior therapy with imatinib and have the Bcr-Abl T315I mutation.
› Verified 5 days ago
News Archive
The Hemophilia Federation of America (HFA) expresses its concern regarding the ongoing labor issues involving the Teamsters Local 929 and the American Red Cross of Pennsylvania /New Jersey.
The Association for Professionals in Infection Control and Epidemiology (APIC) has created a new award to recognize healthcare CEOs and administrators that support infection prevention and control efforts throughout their facilities. The new APIC Healthcare Administrator Award will honor a member of a healthcare facility's executive team (CEO, COO, CFO, CMO, CNO) who has demonstrated significant and sustained support of the organization's infection prevention team.
AHF's Magic Johnson ‘Testing America' Tour, a six month, 48 state national cross country HIV testing tour, arrives in Columbia, South Carolina to host free HIV testing events, along with local partner South Carolina HIV/AIDS Council, today and tomorrow, March 3rd and 4th from 10:00 am to 5:00 pm. All are welcome to attend.
Benitec Limited (ASX: BLT), (PINK:BNIKF), a world leader in expressed gene silencing for human therapeutics, is pleased to announce that the United States Patent and Trademark Office (USPTO) has today indicated that it is issuing the Re-examination Certificate, the formal final step in the USPTO's confirmation of patentability of claims in the key ‘099 Graham Patent [US Patent No. 6,573,099] "Genetic Constructs for Delaying or Repressing the Expression of a Target Gene", the wide-ranging platform technology patent covering the use of expressed RNA interference (RNAi) in human therapeutic applications.
ChemGenex Pharmaceuticals announces that the U.S. Food and Drug Administration's Office of Oncology Drug Products has issued a complete response letter regarding the new drug application for OMAPRO for the treatment of adults with chronic myeloid leukemia who have failed prior therapy with imatinib and have the Bcr-Abl T315I mutation.
› Verified 5 days ago
Novacare Prosthetics & Orthotics Type: Prosthetic/Orthotic Supplier Location: 1931 S Washburn St, Oshkosh, Wisconsin 54904 Phone: (920) 426-1231 | |
Aurora Vision Center Oshkosh Type: Eyewear Supplier (Equipment, not the service) Location: 700 N Westhaven Dr, Oshkosh, Wisconsin 54904 Phone: (920) 456-2002 | |
Aurora Pharmacy Type: Clinic Pharmacy Location: 135 Jackson St, Oshkosh, Wisconsin 54901 Phone: (920) 303-8140 | |
Aurora Pharmacy Inc Type: Pharmacy Location: 414 Doctors Ct, Oshkosh, Wisconsin 54901 Phone: (920) 303-5006 | |
Aurora Pharmacy Inc Type: Pharmacy Location: 855 N Westhaven Dr, Oshkosh, Wisconsin 54904 Phone: (920) 303-8830 |